APO Research
Talk to an analyst

APO RESEARCH · REPORT

Preventive Medicine for Pets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Preventive Medicine for Pets Industry Growth and Trends Forecast to 2032

20 December 2025106 pages

Choose your research edition.

Industry ResearchPreventive Medicine for Pets Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Preventive Medicine for Pets Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Preventive Medicine for Pets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preventive Medicine for Pets Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Preventive Medicine for Pets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Preventive Medicine for Pets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Preventive Medicine for Pets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Preventive Medicine for Pets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Preventive Medicine for Pets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Preventive Medicine for Pets include Zoetis, Merck, Wuhan chopperlvya, Virbac, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun and Elanco, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Preventive Medicine for Pets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Preventive Medicine for Pets market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Preventive Medicine for Pets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Preventive Medicine for Pets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Preventive Medicine for Pets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Preventive Medicine for Pets Market by Company

Zoetis

Merck

Wuhan chopperlvya

Virbac

Vetoquinol

Ouro Fino Saude

Norbrook

Jindun

Elanco

Dechra Veterinary Products

Ceva

CAHIC

Boehringer Ingelheim

Preventive Medicine for Pets Segment by Type

Powder

Liquid

Preventive Medicine for Pets Segment by Application

Reptile

Cat

Dog

Other

Preventive Medicine for Pets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preventive Medicine for Pets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preventive Medicine for Pets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preventive Medicine for Pets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Preventive Medicine for Pets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Preventive Medicine for Pets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Powder Table 2. Major Company of Liquid Table 3. Global Preventive Medicine for Pets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Preventive Medicine for Pets Sales by Type (2021-2026) & (k units) Table 5. Global Preventive Medicine for Pets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Preventive Medicine for Pets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Preventive Medicine for Pets Sales Market Share in Value by Type (2021-2026) Table 8. Global Preventive Medicine for Pets Price by Type (2021-2026) & (US$/unit) Table 9. Global Preventive Medicine for Pets Sales by Type (2027-2032) & (k units) Table 10. Global Preventive Medicine for Pets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Preventive Medicine for Pets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Preventive Medicine for Pets Sales Market Share in Value by Type (2027-2032) Table 13. Global Preventive Medicine for Pets Price by Type (2027-2032) & (US$/unit) Table 14. North America Preventive Medicine for Pets Sales by Type (2021-2026) & (k units) Table 15. North America Preventive Medicine for Pets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Preventive Medicine for Pets Sales by Type (2021-2026) & (k units) Table 17. Europe Preventive Medicine for Pets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Preventive Medicine for Pets Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Preventive Medicine for Pets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Preventive Medicine for Pets Sales by Type (2021-2026) & (k units) Table 21. Latin America Preventive Medicine for Pets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Preventive Medicine for Pets Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Preventive Medicine for Pets Sales by Type (2021-2026) & (US$ Million) Table 24. Preventive Medicine for Pets Industry Trends Table 25. Preventive Medicine for Pets Industry Drivers Table 26. Preventive Medicine for Pets Industry Opportunities and Challenges Table 27. Preventive Medicine for Pets Industry Restraints Table 28. Global Preventive Medicine for Pets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Preventive Medicine for Pets Revenue Market Share by Company (2021-2026) Table 30. Global Preventive Medicine for Pets Sales by Company (2021-2026) & (k units) Table 31. Global Preventive Medicine for Pets Sales Share by Company (2021-2026) Table 32. Global Preventive Medicine for Pets Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Preventive Medicine for Pets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Preventive Medicine for Pets Major Company Production Sites and Headquarters Table 35. Global Preventive Medicine for Pets Company, Product Type & Application Table 36. Global Preventive Medicine for Pets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Preventive Medicine for Pets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Preventive Medicine for Pets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Preventive Medicine for Pets Sales by Region (2021-2026) & (k units) Table 41. Global Preventive Medicine for Pets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Preventive Medicine for Pets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Preventive Medicine for Pets Sales Market Share in Value by Region (2021-2026) Table 44. Global Preventive Medicine for Pets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Preventive Medicine for Pets Sales by Region (2027-2032) & (k units) Table 46. Global Preventive Medicine for Pets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Preventive Medicine for Pets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Preventive Medicine for Pets Sales Market Share in Value by Region (2027-2032) Table 49. Global Preventive Medicine for Pets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Preventive Medicine for Pets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Preventive Medicine for Pets Sales by Application (2021-2026) & (k units) Table 52. Global Preventive Medicine for Pets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Preventive Medicine for Pets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Preventive Medicine for Pets Sales Market Share in Value by Application (2021-2026) Table 55. Global Preventive Medicine for Pets Price by Application (2021-2026) & (US$/unit) Table 56. Global Preventive Medicine for Pets Sales by Application (2027-2032) & (k units) Table 57. Global Preventive Medicine for Pets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Preventive Medicine for Pets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Preventive Medicine for Pets Sales Market Share in Value by Application (2027-2032) Table 60. Global Preventive Medicine for Pets Price by Application (2027-2032) & (US$/unit) Table 61. North America Preventive Medicine for Pets Sales by Application (2021-2026) & (k units) Table 62. North America Preventive Medicine for Pets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Preventive Medicine for Pets Sales by Application (2021-2026) & (k units) Table 64. Europe Preventive Medicine for Pets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Preventive Medicine for Pets Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Preventive Medicine for Pets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Preventive Medicine for Pets Sales by Application (2021-2026) & (k units) Table 68. Latin America Preventive Medicine for Pets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Preventive Medicine for Pets Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Preventive Medicine for Pets Sales by Application (2021-2026) & (US$ Million) Table 71. Zoetis Company Information Table 72. Zoetis Business Overview Table 73. Zoetis Preventive Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Zoetis Preventive Medicine for Pets Product Portfolio Table 75. Zoetis Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Preventive Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Merck Preventive Medicine for Pets Product Portfolio Table 80. Merck Recent Development Table 81. Wuhan chopperlvya Company Information Table 82. Wuhan chopperlvya Business Overview Table 83. Wuhan chopperlvya Preventive Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Wuhan chopperlvya Preventive Medicine for Pets Product Portfolio Table 85. Wuhan chopperlvya Recent Development Table 86. Virbac Company Information Table 87. Virbac Business Overview Table 88. Virbac Preventive Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Virbac Preventive Medicine for Pets Product Portfolio Table 90. Virbac Recent Development Table 91. Vetoquinol Company Information Table 92. Vetoquinol Business Overview Table 93. Vetoquinol Preventive Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Vetoquinol Preventive Medicine for Pets Product Portfolio Table 95. Vetoquinol Recent Development Table 96. Ouro Fino Saude Company Information Table 97. Ouro Fino Saude Business Overview Table 98. Ouro Fino Saude Preventive Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Ouro Fino Saude Preventive Medicine for Pets Product Portfolio Table 100. Ouro Fino Saude Recent Development Table 101. Norbrook Company Information Table 102. Norbrook Business Overview Table 103. Norbrook Preventive Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Norbrook Preventive Medicine for Pets Product Portfolio Table 105. Norbrook Recent Development Table 106. Jindun Company Information Table 107. Jindun Business Overview Table 108. Jindun Preventive Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Jindun Preventive Medicine for Pets Product Portfolio Table 110. Jindun Recent Development Table 111. Elanco Company Information Table 112. Elanco Business Overview Table 113. Elanco Preventive Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Elanco Preventive Medicine for Pets Product Portfolio Table 115. Elanco Recent Development Table 116. Dechra Veterinary Products Company Information Table 117. Dechra Veterinary Products Business Overview Table 118. Dechra Veterinary Products Preventive Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Dechra Veterinary Products Preventive Medicine for Pets Product Portfolio Table 120. Dechra Veterinary Products Recent Development Table 121. Ceva Company Information Table 122. Ceva Business Overview Table 123. Ceva Preventive Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Ceva Preventive Medicine for Pets Product Portfolio Table 125. Ceva Recent Development Table 126. CAHIC Company Information Table 127. CAHIC Business Overview Table 128. CAHIC Preventive Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. CAHIC Preventive Medicine for Pets Product Portfolio Table 130. CAHIC Recent Development Table 131. Boehringer Ingelheim Company Information Table 132. Boehringer Ingelheim Business Overview Table 133. Boehringer Ingelheim Preventive Medicine for Pets Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Boehringer Ingelheim Preventive Medicine for Pets Product Portfolio Table 135. Boehringer Ingelheim Recent Development Table 136. North America Preventive Medicine for Pets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. North America Preventive Medicine for Pets Sales by Country (2021-2026) & (k units) Table 138. North America Preventive Medicine for Pets Sales Market Share by Country (2021-2026) Table 139. North America Preventive Medicine for Pets Sales Forecast by Country (2027-2032) & (k units) Table 140. North America Preventive Medicine for Pets Sales Market Share Forecast by Country (2027-2032) Table 141. North America Preventive Medicine for Pets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Preventive Medicine for Pets Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Preventive Medicine for Pets Market Share by Country (2021-2026) Table 144. North America Preventive Medicine for Pets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Preventive Medicine for Pets Market Share Forecast by Country (2027-2032) Table 146. Europe Preventive Medicine for Pets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Europe Preventive Medicine for Pets Sales by Country (2021-2026) & (k units) Table 148. Europe Preventive Medicine for Pets Sales Market Share by Country (2021-2026) Table 149. Europe Preventive Medicine for Pets Sales Forecast by Country (2027-2032) & (k units) Table 150. Europe Preventive Medicine for Pets Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Preventive Medicine for Pets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Preventive Medicine for Pets Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Preventive Medicine for Pets Market Share by Country (2021-2026) Table 154. Europe Preventive Medicine for Pets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Preventive Medicine for Pets Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Preventive Medicine for Pets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Preventive Medicine for Pets Sales by Country (2021-2026) & (k units) Table 158. Asia-Pacific Preventive Medicine for Pets Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Preventive Medicine for Pets Sales Forecast by Country (2027-2032) & (k units) Table 160. Asia-Pacific Preventive Medicine for Pets Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Preventive Medicine for Pets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Preventive Medicine for Pets Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Preventive Medicine for Pets Market Share by Country (2021-2026) Table 164. Asia-Pacific Preventive Medicine for Pets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Preventive Medicine for Pets Market Share Forecast by Country (2027-2032) Table 166. Latin America Preventive Medicine for Pets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Latin America Preventive Medicine for Pets Sales by Country (2021-2026) & (k units) Table 168. Latin America Preventive Medicine for Pets Sales Market Share by Country (2021-2026) Table 169. Latin America Preventive Medicine for Pets Sales Forecast by Country (2027-2032) & (k units) Table 170. Latin America Preventive Medicine for Pets Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Preventive Medicine for Pets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Preventive Medicine for Pets Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Preventive Medicine for Pets Market Share by Country (2021-2026) Table 174. Latin America Preventive Medicine for Pets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Preventive Medicine for Pets Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Preventive Medicine for Pets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Preventive Medicine for Pets Sales by Country (2021-2026) & (k units) Table 178. Middle East and Africa Preventive Medicine for Pets Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Preventive Medicine for Pets Sales Forecast by Country (2027-2032) & (k units) Table 180. Middle East and Africa Preventive Medicine for Pets Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Preventive Medicine for Pets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Preventive Medicine for Pets Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Preventive Medicine for Pets Market Share by Country (2021-2026) Table 184. Middle East and Africa Preventive Medicine for Pets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Preventive Medicine for Pets Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Preventive Medicine for Pets Distributors List Table 189. Preventive Medicine for Pets Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Preventive Medicine for Pets Image Figure 2. Global Preventive Medicine for Pets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Preventive Medicine for Pets Market Size (2021-2032) & (US$ Million) Figure 4. Global Preventive Medicine for Pets Sales (2021-2032) & (k units) Figure 5. Powder Image Figure 6. Global Powder Sales YoY Growth (2021-2032) & (k units) Figure 7. Liquid Image Figure 8. Global Liquid Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Preventive Medicine for Pets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Preventive Medicine for Pets Market Share by Type 2025 VS 2032 Figure 11. North America Preventive Medicine for Pets Sales Market Share in Volume by Type in 2025 Figure 12. North America Preventive Medicine for Pets Sales Market Share in Value by Type in 2025 Figure 13. Europe Preventive Medicine for Pets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Preventive Medicine for Pets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Preventive Medicine for Pets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Preventive Medicine for Pets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Preventive Medicine for Pets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Preventive Medicine for Pets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Preventive Medicine for Pets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Preventive Medicine for Pets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Preventive Medicine for Pets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Reptile Image Figure 24. Global Reptile Sales YoY Growth (2021-2032) & (k units) Figure 25. Cat Image Figure 26. Global Cat Sales YoY Growth (2021-2032) & (k units) Figure 27. Dog Image Figure 28. Global Dog Sales YoY Growth (2021-2032) & (k units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Preventive Medicine for Pets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Preventive Medicine for Pets Market Share by Application 2025 VS 2032 Figure 33. North America Preventive Medicine for Pets Sales Market Share in Volume by Application in 2025 Figure 34. North America Preventive Medicine for Pets Sales Market Share in Value by Application in 2025 Figure 35. Europe Preventive Medicine for Pets Sales Market Share in Volume by Application in 2025 Figure 36. Europe Preventive Medicine for Pets Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Preventive Medicine for Pets Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Preventive Medicine for Pets Sales Market Share in Value by Application in 2025 Figure 39. Latin America Preventive Medicine for Pets Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Preventive Medicine for Pets Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Preventive Medicine for Pets Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Preventive Medicine for Pets Sales Market Share in Value by Application in 2025 Figure 43. North America Preventive Medicine for Pets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Preventive Medicine for Pets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Preventive Medicine for Pets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Preventive Medicine for Pets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Preventive Medicine for Pets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Preventive Medicine for Pets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Preventive Medicine for Pets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Preventive Medicine for Pets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Preventive Medicine for Pets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Preventive Medicine for Pets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Preventive Medicine for Pets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Preventive Medicine for Pets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Preventive Medicine for Pets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Preventive Medicine for Pets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Preventive Medicine for Pets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Preventive Medicine for Pets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Preventive Medicine for Pets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Preventive Medicine for Pets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Preventive Medicine for Pets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Preventive Medicine for Pets Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Preventive Medicine for Pets Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Preventive Medicine for Pets Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Liquid
Applications
  • Reptile
  • Cat
  • Dog
  • Other
Companies covered
  • Zoetis
  • Merck
  • Wuhan chopperlvya
  • Virbac
  • Vetoquinol
  • Ouro Fino Saude
  • Norbrook
  • Jindun
  • Elanco
  • Dechra Veterinary Products
  • Ceva
  • CAHIC
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Preventive Medicine for Pets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Preventive Medicine for Pets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Preventive Medicine for Pets Market by Type
  6. 1.3.1 Powder
  7. 1.3.2 Liquid
  8. 1.4 Global Preventive Medicine for Pets Market Size by Type
  9. 1.4.1 Global Preventive Medicine for Pets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Preventive Medicine for Pets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Preventive Medicine for Pets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Preventive Medicine for Pets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Preventive Medicine for Pets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Preventive Medicine for Pets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Preventive Medicine for Pets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Preventive Medicine for Pets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Preventive Medicine for Pets Industry Trends
  2. 2.2 Preventive Medicine for Pets Industry Drivers
  3. 2.3 Preventive Medicine for Pets Industry Opportunities and Challenges
  4. 2.4 Preventive Medicine for Pets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Preventive Medicine for Pets Revenue (2021-2026)
  2. 3.2 Global Top Players by Preventive Medicine for Pets Sales (2021-2026)
  3. 3.3 Global Top Players by Preventive Medicine for Pets Price (2021-2026)
  4. 3.4 Global Preventive Medicine for Pets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Preventive Medicine for Pets Major Company Production Sites & Headquarters
  6. 3.6 Global Preventive Medicine for Pets Company, Product Type & Application
  7. 3.7 Global Preventive Medicine for Pets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Preventive Medicine for Pets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Preventive Medicine for Pets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Preventive Medicine for Pets Tier 1, Tier 2, and Tier 3
4 Preventive Medicine for Pets Regional Status and Outlook
  1. 4.1 Global Preventive Medicine for Pets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Preventive Medicine for Pets Historic Market Size by Region
  3. 4.2.1 Global Preventive Medicine for Pets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Preventive Medicine for Pets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Preventive Medicine for Pets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Preventive Medicine for Pets Forecasted Market Size by Region
  7. 4.3.1 Global Preventive Medicine for Pets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Preventive Medicine for Pets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Preventive Medicine for Pets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Preventive Medicine for Pets by Application
  1. 5.1 Preventive Medicine for Pets Market by Application
  2. 5.1.1 Reptile
  3. 5.1.2 Cat
  4. 5.1.3 Dog
  5. 5.1.4 Other
  6. 5.2 Global Preventive Medicine for Pets Market Size by Application
  7. 5.2.1 Global Preventive Medicine for Pets Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Preventive Medicine for Pets Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Preventive Medicine for Pets Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Preventive Medicine for Pets Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Preventive Medicine for Pets Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Preventive Medicine for Pets Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Preventive Medicine for Pets Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Preventive Medicine for Pets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zoetis
  2. 6.1.1 Zoetis Company Information
  3. 6.1.2 Zoetis Business Overview
  4. 6.1.3 Zoetis Preventive Medicine for Pets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zoetis Preventive Medicine for Pets Product Portfolio
  6. 6.1.5 Zoetis Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Preventive Medicine for Pets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Preventive Medicine for Pets Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Wuhan chopperlvya
  14. 6.3.1 Wuhan chopperlvya Company Information
  15. 6.3.2 Wuhan chopperlvya Business Overview
  16. 6.3.3 Wuhan chopperlvya Preventive Medicine for Pets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Wuhan chopperlvya Preventive Medicine for Pets Product Portfolio
  18. 6.3.5 Wuhan chopperlvya Recent Developments
  19. 6.4 Virbac
  20. 6.4.1 Virbac Company Information
  21. 6.4.2 Virbac Business Overview
  22. 6.4.3 Virbac Preventive Medicine for Pets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Virbac Preventive Medicine for Pets Product Portfolio
  24. 6.4.5 Virbac Recent Developments
  25. 6.5 Vetoquinol
  26. 6.5.1 Vetoquinol Company Information
  27. 6.5.2 Vetoquinol Business Overview
  28. 6.5.3 Vetoquinol Preventive Medicine for Pets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Vetoquinol Preventive Medicine for Pets Product Portfolio
  30. 6.5.5 Vetoquinol Recent Developments
  31. 6.6 Ouro Fino Saude
  32. 6.6.1 Ouro Fino Saude Company Information
  33. 6.6.2 Ouro Fino Saude Business Overview
  34. 6.6.3 Ouro Fino Saude Preventive Medicine for Pets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ouro Fino Saude Preventive Medicine for Pets Product Portfolio
  36. 6.6.5 Ouro Fino Saude Recent Developments
  37. 6.7 Norbrook
  38. 6.7.1 Norbrook Company Information
  39. 6.7.2 Norbrook Business Overview
  40. 6.7.3 Norbrook Preventive Medicine for Pets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Norbrook Preventive Medicine for Pets Product Portfolio
  42. 6.7.5 Norbrook Recent Developments
  43. 6.8 Jindun
  44. 6.8.1 Jindun Company Information
  45. 6.8.2 Jindun Business Overview
  46. 6.8.3 Jindun Preventive Medicine for Pets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Jindun Preventive Medicine for Pets Product Portfolio
  48. 6.8.5 Jindun Recent Developments
  49. 6.9 Elanco
  50. 6.9.1 Elanco Company Information
  51. 6.9.2 Elanco Business Overview
  52. 6.9.3 Elanco Preventive Medicine for Pets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Elanco Preventive Medicine for Pets Product Portfolio
  54. 6.9.5 Elanco Recent Developments
  55. 6.10 Dechra Veterinary Products
  56. 6.10.1 Dechra Veterinary Products Company Information
  57. 6.10.2 Dechra Veterinary Products Business Overview
  58. 6.10.3 Dechra Veterinary Products Preventive Medicine for Pets Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Dechra Veterinary Products Preventive Medicine for Pets Product Portfolio
  60. 6.10.5 Dechra Veterinary Products Recent Developments
  61. 6.11 Ceva
  62. 6.11.1 Ceva Company Information
  63. 6.11.2 Ceva Business Overview
  64. 6.11.3 Ceva Preventive Medicine for Pets Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Ceva Preventive Medicine for Pets Product Portfolio
  66. 6.11.5 Ceva Recent Developments
  67. 6.12 CAHIC
  68. 6.12.1 CAHIC Company Information
  69. 6.12.2 CAHIC Business Overview
  70. 6.12.3 CAHIC Preventive Medicine for Pets Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 CAHIC Preventive Medicine for Pets Product Portfolio
  72. 6.12.5 CAHIC Recent Developments
  73. 6.13 Boehringer Ingelheim
  74. 6.13.1 Boehringer Ingelheim Company Information
  75. 6.13.2 Boehringer Ingelheim Business Overview
  76. 6.13.3 Boehringer Ingelheim Preventive Medicine for Pets Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Boehringer Ingelheim Preventive Medicine for Pets Product Portfolio
  78. 6.13.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America Preventive Medicine for Pets Sales by Country
  2. 7.1.1 North America Preventive Medicine for Pets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Preventive Medicine for Pets Sales by Country (2021-2026)
  4. 7.1.3 North America Preventive Medicine for Pets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Preventive Medicine for Pets Market Size by Country
  6. 7.2.1 North America Preventive Medicine for Pets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Preventive Medicine for Pets Market Size by Country (2021-2026)
  8. 7.2.3 North America Preventive Medicine for Pets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Preventive Medicine for Pets Sales by Country
  2. 8.1.1 Europe Preventive Medicine for Pets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Preventive Medicine for Pets Sales by Country (2021-2026)
  4. 8.1.3 Europe Preventive Medicine for Pets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Preventive Medicine for Pets Market Size by Country
  6. 8.2.1 Europe Preventive Medicine for Pets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Preventive Medicine for Pets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Preventive Medicine for Pets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Preventive Medicine for Pets Sales by Country
  2. 9.1.1 Asia-Pacific Preventive Medicine for Pets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Preventive Medicine for Pets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Preventive Medicine for Pets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Preventive Medicine for Pets Market Size by Country
  6. 9.2.1 Asia-Pacific Preventive Medicine for Pets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Preventive Medicine for Pets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Preventive Medicine for Pets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Preventive Medicine for Pets Sales by Country
  2. 10.1.1 South America Preventive Medicine for Pets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Preventive Medicine for Pets Sales by Country (2021-2026)
  4. 10.1.3 South America Preventive Medicine for Pets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Preventive Medicine for Pets Market Size by Country
  6. 10.2.1 South America Preventive Medicine for Pets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Preventive Medicine for Pets Market Size by Country (2021-2026)
  8. 10.2.3 South America Preventive Medicine for Pets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Preventive Medicine for Pets Sales by Country
  2. 11.1.1 Middle East and Africa Preventive Medicine for Pets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Preventive Medicine for Pets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Preventive Medicine for Pets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Preventive Medicine for Pets Market Size by Country
  6. 11.2.1 Middle East and Africa Preventive Medicine for Pets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Preventive Medicine for Pets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Preventive Medicine for Pets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Preventive Medicine for Pets Value Chain Analysis
  2. 12.1.1 Preventive Medicine for Pets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Preventive Medicine for Pets Production Mode & Process
  7. 12.2 Preventive Medicine for Pets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Preventive Medicine for Pets Distributors
  10. 12.2.3 Preventive Medicine for Pets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst